Get support from ILCA to conduct your research!
ILCA is pleased to offer you the opportunity to benefit from funding to perform your research and contribute to liver cancer science through its Fellowship Programme.
You can now apply for the ILCA Fellowship 2020 and be considered for receiving a €40,000 grant.
Application deadline: 21 February 2020 (23:59 CET)
HOW TO APPLY?
Through the Fellowship Programme, ILCA supports research in all liver cancer related disciplines by encouraging young scientists to develop their career in liver cancer research.
The aims of this key initiative are to:
- Encourage young investigators to pursue a career in liver cancer research
- Develop the potential of outstanding young scientists and encourage research in liver cancer disciplines
- Foster career development for individuals performing research in a liver cancer related area and who have shown commitment to excellence at an early stage of their research study
- Help progress ILCA’s mission to lead a global Community of physicians, scientists and allied professionals through education and research with the goal to better prevent and treat liver cancer
- Promote science through the support of young researchers
- Be under 40 years old and undertaking post-doctoral studies in a liver cancer related discipline
- Candidate should hold a PhD or MD and be pursuing post-doctoral studies which include both basic and/or clinical research. Those in post-MD Residency or Fellowship programmes and engaged in liver cancer research are eligible. Candidates should not hold full-time faculty positions.
- Be an ILCA member* in good standing
- Be supported by a research mentor
* Click here to apply for or renew your membership
All applications will be reviewed by the ILCA Executive Committee. The successful applicant will be notified in March 2020.
Congratulations to the ILCA Fellowship 2019 Awardee!
ILCA is pleased to announce that Dr. Jin Lee, from the Department of Pathology of the School of Medicine, University of California, San Diego, was awarded the ILCA Fellowship 2019.
ILCA will support her research on Immunotherapeutic Target on Unique Mitotic Spindle in Hepatocellular Carcinoma.
Can you please tell us a bit about your research project?
Despite microtubule-binding compound being widely used as a chemotherapeutic in the treatment of various cancers, it has shown disappointing results in liver cancer, since it extensively affects normal cells. Specifically targeting mitosis in cancer cells is considered as a preferred strategy. For this purpose, I am working on study to know whether immune cells can target specifically proliferating cancer cells through unique mitosis machinery and what mechanism they have. For my objectives, I will successfully complete this project with a goal to discover a novel target of HCC and propose a new therapeutic strategy for treatment humans with HCC. I hope this work will contribute in clinic finally.
Why did you get involved in this type of research?
There is nothing nicer than knowing. My pleasure was to discover the undiscovered things and this led me to do basic science research. So far human beings have been suffering from many types of cancer. I believed in basic science is fundamentally essential to the study of the medicine and it is the key of the drug discovery especially for cancer. For this reason, I did get involved in cell biology research and want to know about how tumour cells communicate with other type of cells in tumour microenvironment.
How will the ILCA grant help you?
I am so grateful that ILCA will support my research. It is an honor to receive this prestigious fellowship. The ILCA grant will encourage me to pursue science and to increase self-motivation. It will be a milestone for the next chapter of my career as an independent scientist.
ILCA Fellowship 2018 Awardee
Icahn School of Medicine at Mount Sinai
ILCA is supporting her research on Quantitative MRI for Noninvasive Prediction of Gene Signatures in Hepatocellular Carcinoma